Cancer Moonshoot – Black Swan Research Initiative

Precision Oncology and the Cancer Moonshot: Where Do We Stand?

By imfbsri On September 15, 2016 · Add Comment · In Blog, News & Updates

By imfbsri On January 21, 2016 · Add Comment · In Blog, News & Updates

Black Swan Research Initiative Hits the Ground Running in 2014The International Myeloma Foundation (IMF) Black Swan Research Initiative (BSRI) [...]
Measuring Minimal Residual Disease in MyelomaA recent editorial in Leukemia authored by doctors Shaji Kumar [...]
Onyx Pharmaceuticals partners with IMF to support Black Swan Research Initiative®North Hollywood CA and South San Francisco CA December 6 [...]
Black Swan, Salamanca, and the FDA: Debut of a Highly Sensitive New MRD TestA significant event in the evolution of the IMF’s Black [...]

New myeloma research project follows in the footsteps of iSTOPMM to study myeloma precursorsNow a new project will attempt to replicate iStopMM’s large [...]
BSRI researchers identify good-risk and poor-risk MRD patientsThis week several reports provide good news for myeloma patients. [...]
iStopMM - One Year UpdateThe International Myeloma Foundation (IMF) is excited to announce that [...]
Black Swan Research Initiative® Progress Report - 2017The IMF’s signature Black Swan Research Initiative® (BSRI®) is forging [...]

%d bloggers like this: